Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It happenned January 20th
Thank you very much!!
BooDog
Is this the same Aspire as who is funding us?
http://otce.finra.org/DailyList
Have you decided if you are able to make ASCO yet? Thanks in advance
I just looked up my last buy and it was 12-4-13 at 1.45. Never ever sold a share and the current price is getting me excited again to buy once again. The same things on this board was happening at that time also, usually an indication we near or at the bottom. So I will be hoping for one more take down this week. I feel like either direction it goes I win since I am a LONG TERM INVESTOR. Glta
Does anyone think there is a good chance uplisting will occur on May 11, the same day the 10-K will likely come out. That way new investors would have most of the information right in front of them to decide to invest.
Their was posts in the past that the average time from application to nasdaq to uplisting was 6 weeks
CELLCEUTIX PROVIDES UPDATE TO SHAREHOLDERS
My Fellow Cellceutix Shareholders,
We are pleased to inform you that this past Thursday (February 5th) we submitted an application to the NASDAQ Exchange for listing on the NASDAQ Capital Markets. We have already met several of the NASDAQ listing requirements and are working to meet other requirements with respect to Independent Directors and establishing certain committees. Our corporate counsel and NASDAQ have advised that these requirements can be fulfilled during the application process. As previously discussed, we have been performing our due diligence and interviewing many interested individuals wishing to join Cellceutix in these capacities. The names of the prospective Directors will be submitted to NASDAQ for their vetting process to ensure that the individuals meet the requirements per NASDAQ definitions. We look forward to announcing these people as the processes are completed. Thank you for your continued support.
Sincerely,
The Cellceutix Team
- See more at: http://cellceutix.com/best-yet-to-come/#sthash.VOdjDGqz.dpuf
yes, thank you sir
Boo Dog or TOB posted a link to when ctix gets approved by nasdaq for uplisting, can someone find, it was up to the minute, tyia
I guess a couple people were hoping for al gore to be on the board
Awesome, Thanks!!
thanks Boo!!
Anyone know what time today their last presentation is? Is it 10 a.m. central time so maybe bye noon we can see it?
I have a hunch that they are enrolling the last patient to make the 40 and gonna call it quits on this phase I
Could it be that the paper that was asked to be prepared will be made public before asco?
I Love this part the best, Kevetrin going to Phase 2 in europe,looking for complete remission, should bring in a bunch of europeon investors?
Kevetrin- Acute Myelogenous Leukemia
We have previously announced that Kevetrin will be studied in a trial being sponsored by the University of Bologna and its European partners. The initiation of this trial was intentionally delayed pending further evaluation of Kevetrin dosing in our ongoing Phase 1 study. We are pleased to report we have been notified that based upon the data from the Phase 1 study, the original protocol has been revised and expanded from what was originally planned to be a Phase 1b study into a Phase 2 trial evaluating Kevetrin as a single agent or in combination with cytarabine in patients with Acute Myelogenous Leukemia (AML). Over 100 patients are expected to be enrolled in the trial. The new protocol will be submitted in May by the principal investigator at the University of Bologna to the institutional committee. This is an important trial for Kevetrin as these AML patients will be receiving Kevetrin on multiple consecutive days, which we believe will increase p53 activity. The primary objective of this trial is to evaluate the rate of complete remission of AML in patients receiving Kevetrin alone or in combination with cytarabine. We believe that if the trial shows clinical activity of Kevetrin or Kevetrin plus cytarabine in the treatment of AML, a disease that the American Cancer Society estimates accounts for 20,830 new cases and 10,460 deaths annually in the United States, we will see a substantial rise in interest in Kevetrin for potential use in leukemias.
I believe that would be as of March 15, probably is higher now
This is new
From my broker account, use to show 0% institution ownership
now shows % Held by Institutions 1.06
Thanks again for all your intellect, hope you have more time to spend on this board in the coming times, I know you been busy with other things but always look forward to your honest posts
BK,
So what New information may we learn from the ASCO presentation?
thanks in advance
Are people expecting the big update tomorrow since it is following the end of the quarter?
What tough questions were asked? He never replies to me, thanks in advance if you post the tough questions
Thank you, was thinking they would uplist before all the upcoming catalysts
John B,
Do you have that nasdaq time schedule you posted awhile back? Am thinking we are about two weeks away from uplisting
THANKS
Did you know about that gap also?
Gap filled from Dec.8 3.36-340 Glad that is over with, was waiting a long time for that to fill.
Posted by ctix on their facebook page
http://www.foxnews.com/health/2014/12/16/super-bacteria-found-in-rio-olympic-waters/
BAM!! Have a good weekend all!
Yes we talking about the same article, all is good
Its got many new eyes on it now and I expect it to spill over into next week after people have time to read the article and do their own DD.
Best of Luck
Every morning I get a list of SA articles( about 30 of them) and that article was one of them, I can't remember in the last year seeing any ctix article on SA that got e-mailed to me in the group like that, also it has pro highlighted when I click the article
Its not a new article, but yesterdays article only came to people who had ctix alerts(which stated only 2,100 people and I was one of them). Otherwise everyone else gets yesterdays pro SA articles around the opening bell today.
About this article
Emailed to: 2,147 people who get CTIX real-time alerts and 493,331 people who get Investing Ideas daily.
whale spotted
Looking for a rise in price today, only 2,100 people got the seeking alpha real time alert yesterday, but 5 minutes ago millions of people got the article since it was a pro article you did not have to be signed up for ctix alert but just signed up for seeking alpha
good luck
thanks they have a 2.25 price target in one month for whichever one it is